FRX

Fennec Pharms

15.04

-0.25-1.64%

Closed15:56 09/24 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE14.66/15.29

TODAY RANGE14.45-15.04

VOL1.39K

MARKET CAP527.28M

52 WEEK RANGE7.59-17.64

AVG VOL (3M)878

% TURNOVER0.00%

TURNOVER4.50K

P/E (TTM)-90.8213

% RANGE3.86%

EPS(TTM)-0.1656

P/E(FORWARD)36.05

P/B8.74

BVPS1.721

DIVIDEND--

P/S8.39

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP424.67M

SHARES OUTSTANDING35.06M

NEXT EARNINGS11/11-11/16

FREE FLOAT28.24M

LOT SIZE100

EX-DATE09/05/2014

News

Press Releases

Financial Reports

Profile

Dow Jones·09/09 11:28
Fennec Pharmaceuticals Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Dow Jones·08/12 17:00
Fennec Pharmaceuticals Price Target Raised to $18.00/Share From $16.00 by B. Riley Securities
Dow Jones·08/12 16:14
Fennec Pharmaceuticals Is Maintained at Outperform by Wedbush
Dow Jones·08/12 16:14
Fennec Pharmaceuticals Price Target Raised to $16.00/Share From $13.00 by Wedbush
Dow Jones·08/11 11:07
*Fennec Pharmaceuticals 2Q EPS 5c >FRX.T
Dow Jones·08/11 11:07
*Fennec Pharmaceuticals 2Q Rev $17.9M >FRX.T
Dow Jones·05/22 11:00
Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·05/22 11:00
Fennec Pharmaceuticals Price Target Raised to $16.00/Share From $13.00 by HC Wainwright & Co.
Dow Jones·05/14 10:30
*Fennec Pharmaceuticals 1Q Rev $15.1M >FRX.T
Dow Jones·05/14 10:30
*Fennec Pharmaceuticals 1Q EPS 1c >FRX.T
Dow Jones·04/16 13:39
Fennec Pharmaceuticals Price Target Maintained With a $13.00/Share by Wedbush
Dow Jones·03/24 14:33
Fennec Pharmaceuticals Stock Falls on Widened 4Q Loss
Dow Jones·03/24 11:05
*Fennec Pharmaceuticals 4Q Rev $13.8M >FRX.T
Dow Jones·03/24 11:03
*Fennec Pharmaceuticals 4Q Loss/Shr 17c >FRX.T
Dow Jones·01/09 13:32
Fennec Pharmaceuticals Price Target Announced at $18.00/Share by Piper Sandler

Same Industry

Name/Symbol

Change%

Price

No data yet, let's see others

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.

English